| Identification | Back Directory | [Name]
4-Piperidinol, 1-[6-(5'-chloro-3,5-dimethyl[2,4'-bipyridin]-2'-yl)-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-2-yl]- | [CAS]
1567963-99-8 | [Synonyms]
SMO-IN-4
4-Piperidinol, 1-[6-(5'-chloro-3,5-dimethyl[2,4'-bipyridin]-2'-yl)-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-2-yl]- | [Molecular Formula]
C24H27ClN6O | [MOL File]
1567963-99-8.mol | [Molecular Weight]
450.96 |
| Hazard Information | Back Directory | [Uses]
SMO-IN-4 (Compound 24) is a potent and orally active smoothened antagonist (IC50: 24 nM). SMO-IN-4 has antitumor activity[1]. | [in vivo]
SMO-IN-4 (50 mg/kg, daily by oral gavage) leads to regression of subcutaneous tumor in a subcutaneous xenograft model of Ptch1+/- mouse medulloblastoma[2].
PK properties of SMO-IN-4 (compound 24)[2].
| Species | Dose (mg/kg) | AUC0-24h (ng·h/mL) | Cmax (ng/mL) | t1/2 (h) | F% | | Mouse | p.o. (10 mg/kg) | 4183 | 4132 | 1.0 | 49 | | Rat | p.o. (10 mg/kg) | 5541 | 2180 | 2.3 | 62 | | Dog | p.o. (5 mg/kg) | 7656 | 1300 | 5.4 | 72 |
| [References]
[1] Lu W, et al. Design, Synthesis, and Structure-Activity Relationship of Tetrahydropyrido[4,3-d]pyrimidine Derivatives as Potent Smoothened Antagonists with in Vivo Activity. ACS Chem Neurosci. 2017 Sep 20;8(9):1980-1994. DOI:10.1021/acschemneuro.7b00153 |
|
|